Literature DB >> 18676808

Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling.

Hye-Min Jeon1, Xun Jin, Joong-Seob Lee, Se-Yeong Oh, Young-Woo Sohn, Hyo-Jung Park, Kyeung Min Joo, Woong-Yang Park, Do-Hyun Nam, Ronald A DePinho, Lynda Chin, Hyunggee Kim.   

Abstract

Cellular origins and genetic factors governing the genesis and maintenance of glioblastomas (GBM) are not well understood. Here, we report a pathogenetic role of the developmental regulator Id4 (inhibitor of differentiation 4) in GBM. In primary murine Ink4a/Arf(-/-) astrocytes, and human glioma cells, we provide evidence that enforced Id4 can drive malignant transformation by stimulating increased cyclin E to produce a hyperproliferative profile and by increased Jagged1 expression with Notch1 activation to drive astrocytes into a neural stem-like cell state. Thus, Id4 plays an integral role in the transformation of astrocytes via its combined actions on two-key cell cycle and differentiation regulatory molecules.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676808      PMCID: PMC2492750          DOI: 10.1101/gad.1668708

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  24 in total

1.  High cyclin E/low p27Kip1 expression is associated with poor prognosis in astrocytomas.

Authors:  T Tamiya; S Mizumatsu; Y Ono; T Abe; K Matsumoto; T Furuta; T Ohmoto
Journal:  Acta Neuropathol       Date:  2001-04       Impact factor: 17.088

Review 2.  Applying the principles of stem-cell biology to cancer.

Authors:  Ricardo Pardal; Michael F Clarke; Sean J Morrison
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

Review 3.  Notch signaling in development and disease.

Authors:  Emil M Hansson; Urban Lendahl; Gavin Chapman
Journal:  Semin Cancer Biol       Date:  2004-10       Impact factor: 15.707

4.  Id4 regulates neural progenitor proliferation and differentiation in vivo.

Authors:  Kyuson Yun; Akio Mantani; Sonia Garel; John Rubenstein; Mark A Israel
Journal:  Development       Date:  2004-10-06       Impact factor: 6.868

5.  Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.

Authors:  Keith L Ligon; Emmanuelle Huillard; Shwetal Mehta; Santosh Kesari; Hongye Liu; John A Alberta; Robert M Bachoo; Michael Kane; David N Louis; Ronald A Depinho; David J Anderson; Charles D Stiles; David H Rowitch
Journal:  Neuron       Date:  2007-02-15       Impact factor: 17.173

6.  Human neural stem cells: electrophysiological properties of voltage-gated ion channels.

Authors:  T Cho; J H Bae; H B Choi; S S Kim; J G McLarnon; H Suh-Kim; S U Kim; C K Min
Journal:  Neuroreport       Date:  2002-08-07       Impact factor: 1.837

7.  Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells.

Authors:  Jeongwu Lee; Myung Jin Son; Kevin Woolard; Nicholas M Donin; Aiguo Li; Chui H Cheng; Svetlana Kotliarova; Yuri Kotliarov; Jennifer Walling; Susie Ahn; Misuk Kim; Mariam Totonchy; Thomas Cusack; Chibawanye Ene; Hilary Ma; Qin Su; Jean Claude Zenklusen; Wei Zhang; Dragan Maric; Howard A Fine
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

8.  Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.

Authors:  Rossella Galli; Elena Binda; Ugo Orfanelli; Barbara Cipelletti; Angela Gritti; Simona De Vitis; Roberta Fiocco; Chiara Foroni; Francesco Dimeco; Angelo Vescovi
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

9.  Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis.

Authors:  Robert M Bachoo; Elizabeth A Maher; Keith L Ligon; Norman E Sharpless; Suzanne S Chan; Mingjian James You; Yi Tang; Jessica DeFrances; Elizabeth Stover; Ralph Weissleder; David H Rowitch; David N Louis; Ronald A DePinho
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

10.  Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas.

Authors:  Carly Leung; Merel Lingbeek; Olga Shakhova; James Liu; Ellen Tanger; Parvin Saremaslani; Maarten Van Lohuizen; Silvia Marino
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

View more
  56 in total

Review 1.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

Review 2.  Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.

Authors:  Robert Strauss; Petra Hamerlik; André Lieber; Jiri Bartek
Journal:  Mol Ther       Date:  2012-02-07       Impact factor: 11.454

3.  Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence.

Authors:  Candace A Gilbert; Marie-Claire Daou; Richard P Moser; Alonzo H Ross
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

4.  ID4 regulates mammary gland development by suppressing p38MAPK activity.

Authors:  Jie Dong; Shixia Huang; Marian Caikovski; Shaoquan Ji; Amanda McGrath; Myra G Custorio; Chad J Creighton; Paul Maliakkal; Ekaterina Bogoslovskaia; Zhijun Du; Xiaomei Zhang; Michael T Lewis; Fred Sablitzky; Cathrin Brisken; Yi Li
Journal:  Development       Date:  2011-12       Impact factor: 6.868

5.  Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis.

Authors:  Francesco Niola; Xudong Zhao; Devendra Singh; Ryan Sullivan; Angelica Castano; Antonio Verrico; Pietro Zoppoli; Dinorah Friedmann-Morvinski; Erik Sulman; Lindy Barrett; Yuan Zhuang; Inder Verma; Robert Benezra; Ken Aldape; Antonio Iavarone; Anna Lasorella
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

6.  JISTIC: identification of significant targets in cancer.

Authors:  Felix Sanchez-Garcia; Uri David Akavia; Eyal Mozes; Dana Pe'er
Journal:  BMC Bioinformatics       Date:  2010-04-14       Impact factor: 3.169

7.  Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression.

Authors:  Hye-Min Jeon; Sung-Hak Kim; Xun Jin; Jong Bae Park; Se Hoon Kim; Kaushal Joshi; Ichiro Nakano; Hyunggee Kim
Journal:  Cancer Res       Date:  2014-06-24       Impact factor: 12.701

8.  Rab3a promotes brain tumor initiation and progression.

Authors:  Jun-Kyum Kim; Seung-Yup Lee; Chang-Won Park; Suk-Hwang Park; Jinlong Yin; Jaebong Kim; Jae-Bong Park; Jae-Yong Lee; Hyunggee Kim; Sung-Chan Kim
Journal:  Mol Biol Rep       Date:  2014-06-26       Impact factor: 2.316

Review 9.  Cancer stem cells: cell culture, markers, and targets for new therapies.

Authors:  Candace A Gilbert; Alonzo H Ross
Journal:  J Cell Biochem       Date:  2009-12-01       Impact factor: 4.429

10.  Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.

Authors:  Qinghai Liu; David H Nguyen; Qinghua Dong; Peter Shitaku; Kenneth Chung; On Ying Liu; Jonathan L Tso; Jason Y Liu; Veerauo Konkankit; Timothy F Cloughesy; Paul S Mischel; Timothy F Lane; Linda M Liau; Stanley F Nelson; Cho-Lea Tso
Journal:  J Neurooncol       Date:  2009-05-26       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.